Are peptides legal in Australia?
Research peptides are legal to sell and to purchase in Australia when supplied strictly for research use and when no medicinal claims are made. The framework that governs this is the Therapeutic Goods Act 1989. Under that legislation, a product cannot be sold for human therapeutic use without being entered on the Australian Register of Therapeutic Goods, administered by the Therapeutic Goods Administration (TGA). Compounds offered for research and development use, with no medicinal claims and no intent for human consumption, sit outside the medicines-listing regime.
Healius Peptides sells research-grade chemical compounds. The TGA does not authorize Healius to manufacture or supply therapeutic goods for human use, and no product in the catalog is intended for human or veterinary consumption. This research-only stance is the legal basis for Australian supply and applies to other compliant research peptide suppliers in Australia.
Australian customers are responsible for ensuring that their own intended use of any compound complies with the Therapeutic Goods Act, the Poisons Standard, including any Schedule 4 considerations relevant to a given compound, and any state, territory, or institutional rules that may apply. The position taken on this website and on every Healius product page is for research and development use only.
